Eurobiomed

What Eurobiomed does

Eurobiomed is a French competitiveness cluster (pôle de compétitivité) operating as an association loi 1901 from its headquarters at 7 rue François Moisson, 13002 Marseille, with active operational presence across the Sud Provence-Alpes-Côte d'Azur and Occitanie / Pyrénées-Méditerranée regions. Its functional role is to accelerate the availability of health innovations by connecting a community of more than 80% of the innovative health companies in southern France with public and private funding, regulatory and clinical expertise, investor networks, and international market access. Core service programmes include Challenge Stratégique (custom expert advisory), the GO4BIO three-year acceleration programme, and the Invest In Biomed annual fundraising preparation and investor matchmaking programme (entering its 10th edition in 2026), complemented by event and thematic platforms such as Biorezo, Forums des Dirigeants, Skin Excellence, the Enosis Santé alliance, and the CRO Directory. International and digital surface includes Move2Digital (with InExtenso Innovation Croissance, EU/Région Sud/Métropole co-funded), TIGER (EU Interreg Alpine Space e-health initiative), and partnerships with Biocom California, CHU de Nîmes, CHU de Nice, PUI Montpellier, ANR, Bpifrance, France 2030 and ESA/CNES.

The business model is hybrid: an association funded primarily by public regional and European grants (Région Sud, Région Occitanie, FEDER) and supplemented by membership fees from associated companies and partners, with select fee-bearing service programmes (Challenge Stratégique, GO4BIO, Move2Digital) delivered to member SMEs. Distribution relies on direct member engagement, calls for projects, and event-based delivery across Marseille, Montpellier, Nice and Toulouse — no commercial product distribution or SaaS-style revenue stream exists. Pricing is not publicly disclosed. In 2025 the cluster reports that its member community obtained approximately €300M of financing (€124M public + €160M private) and that it organised 40+ community events; 7 member companies won the national i-Lab 2025 innovation competition and 3 Labcom ANR projects labelled by Eurobiomed were awarded in the first 2025 wave. Eurobiomed does not develop proprietary AI but acts as the convening layer for AI-enabled health innovation across its member base.

Governance is led by President Eric Vacaresse, with Claire Naussac as Directrice accompagnement, Emmanuel Le Bouder as Responsable Innovation, and operational contacts including Lamya Rezig, Salim Saifi and Jeoffrey Tagliamonte. Ownership is independent — no parent company is disclosed — and the entity is privately registered (Siren 478 898 349, Code APE 923A) with no public listing.

Name

Eurobiomed

Legal name

Eurobiomed

Website

https://eurobiomed.org

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Eurobiomed is a Marseille-based French competitiveness cluster that accelerates health innovation across southern France (Sud PACA and Occitanie), serving 80%+ of the region's biotech, medtech and e-health innovators with advisory, acceleration and fundraising programmes linked to public and private capital.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Cluster Services

NAICS

Business Associations (81391), Professional, Scientific, and Technical Services (541)

SIC

Services-Misc Health & Allied Services, Nec (8090), International Affairs (9721)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Health innovation cluster
• Biotech acceleration programs
• Medtech strategic advisory
• Fundraising preparation support
• Life sciences networking

Headquarters

HQ city

Marseille

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: Eurobiomed operates as a cluster de compétitivité (competitiveness cluster) primarily funded through public regional support (Région Sud, Région Occitanie, European Union FEDER), with membership fees from associated companies contributing to its operations. It also generates revenue through service offerings such as the Challenge Stratégique advisory, GO4BIO acceleration program, and Invest In Biomed fundraising preparation program.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Eurobiomed is a French competitiveness cluster (pôle de compétitivité) operating as an industry association that accelerates health innovation across the Sud Provence-Alpes-Côte d'Azur and Occitanie / Pyrénées-Méditerranée regions. It provides a portfolio of services — strategic advisory (Challenge Stratégique), startup acceleration (GO4BIO), fundraising preparation and investor matchmaking (Invest In Biomed), thematic communities (Skin Excellence, Enosis Santé), executive networking events (Forums des Dirigeants, Biorezo), CRO directories, and international business development support — connecting innovative biotech, medtech, and e-health companies with public funding, private investors, regulatory expertise, and market access.

Product overview

Eurobiomed is a competitiveness cluster (pôle de compétitivité) that accelerates health innovation across southern France, operating not as a single product company but as a service portfolio spanning advisory, acceleration, fundraising support, and community platforms. Its core service offerings include Challenge Stratégique (custom expert advisory), the GO4BIO acceleration programme (intensive 3-year startup support), and Invest In Biomed (annual fundraising preparation and investor matchmaking programme now in its 10th edition). These are complemented by event-based platforms such as the Biorezo regional startup showcase series, the Skin Excellence thematic initiative, the Enosis Santé alliance, and the Forums des Dirigeants executive networking events. Eurobiomed also provides access to European programmes and international missions, a CRO Directory, and digital transformation support through the Move2Digital and TIGER programmes. The portfolio functions as an integrated ecosystem of interconnected services designed to support companies at every stage from innovation development through international market access.

Differentiator

Problem solved

Functional benefit

Products and services

• Challenge Stratégique Custom strategic advisory service pairing member health innovation companies with qualified experts selected from Eurobiomed's network to address specific strategic challenges.
• GO4BIO Acceleration Programme Intensive acceleration programme enabling selected health innovation startups to reach key value-creation milestones within three years through reinforced support.
• Invest In Biomed Annual fundraising preparation and investor networking programme that helps health innovation companies structure their funding approach and connect with sector-specialized investors; entering its 10th edition in 2026.
• Biorezo Regional startup showcase events held across southern France where emerging health innovation companies pitch their solutions to the broader ecosystem, creating business development opportunities.
• CRO Directory (Annuaire CRO) Directory of Contract Research Organizations (CROs) available to member companies, helping identify suitable research partners.
• Forums des Dirigeants Multi-year executive networking events enabling health sector leaders to develop strategic competencies and build high-quality professional networks.
• European Programmes Support Support services for accessing European funding programmes and international development opportunities for health innovation companies.
• Conventions and Missions International business conventions and mission programmes connecting health innovation companies with global market opportunities.
• Move2Digital Digital transformation diagnostic and roadmap service delivered by InExtenso Innovation Croissance in partnership with Eurobiomed, co-funded by the EU, Région Sud and Métropole Aix-Marseille-Provence, offering free initial audits and tailored digital transition plans for SMEs.
• TIGER Programme European cross-border initiative co-financed by the EU Interreg Alpine Space programme supporting e-health innovators for elderly care, offering market acceleration, expert evaluation, and product validation services via the Tigerpath.eu platform.

Quantifiable outcome

• Member companies obtained nearly 300M€ in 2025 (124M€ public + 160M€ private financing)
• +2 more outcomes

Named customers13 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

18 partnerships are on record, tiered major, significant and minor.

• Biocom CaliforniamajorGTM or Marketing Partner · 29 September 2025Eurobiomed and Biocom California renewed and strengthened their strategic partnership in September 2025 to boost life sciences innovation between southern France and California. The partnership facilitates cross-border connections, investor introductions, and market access for member companies.
• TIGER (Interreg Alpine Space)significantStrategic or Co-development Partner · 25 August 2025TIGER is a European initiative co-funded by the EU Interreg Alpine Space program supporting e-health innovators. Eurobiomed is a founding member and proposes TIGER's services (market acceleration, expert evaluation, product validation) to its member community.
• CHU de NîmesmajorStrategic or Co-development Partner · 5 May 2025Eurobiomed and CHU de Nîmes signed a framework agreement in May 2025 to strengthen collaboration in health innovation R&D project assembly with industry partners, leveraging the CHU's six research platforms and Eurobiomed's business development expertise.
• Pôle Universitaire d'Innovation (PUI) de MontpelliermajorStrategic or Co-development Partner · 7 April 2025Eurobiomed and the PUI de Montpellier signed a partnership convention in April 2025 to advance public research and health sector entrepreneurship together. Eurobiomed leverages its industrial community to connect researchers and companies, while the PUI uses Eurobiomed as a sector referent for evaluating project candidates.
• CHU de NicemajorStrategic or Co-development Partner · 3 December 2024CHU de Nice and Eurobiomed announced the selection of the first Tiers-Lieu d'Expérimentation (experimentation third-place) dedicated to skin health digital solutions. CHU de Nice and Eurobiomed co-pilot the Skin Excellence initiative, creating a world-reference innovation hub for dermatology.
• CISAM (Cité de l'Innovation et des Savoirs Aix-Marseille)majorStrategic or Co-development PartnerCISAM collaborates with Eurobiomed on the RDV Innovation series, bringing together academic, institutional, associative and economic communities around health innovation topics. Eurobiomed is a partner in CISAM's events such as 'Vers une biologie dans l'espace' in July 2026.
• CNES (Centre National d'Etudes Spatiales)significantStrategic or Co-development PartnerCNES collaborates with CISAM and Eurobiomed on space biology innovation events, exploring opportunities in bacteriology, immunology, oncology and dermatology with ESA.
• ESA (European Space Agency)significantStrategic or Co-development PartnerESA partners with CISAM and Eurobiomed on space biology events, including ESA Europe funding opportunities for health innovation projects.
• Université Côte d'AzurmajorStrategic or Co-development PartnerUniversité Côte d'Azur is a key academic partner in the Skin Excellence initiative, contributing research expertise in dermatology, pigmentation mechanisms, and melanoma alongside Eurobiomed's industry network.
• risingSUDmajorGTM or Marketing PartnerrisingSUD is the regional development agency for Sud Provence-Alpes-Côte d'Azur, partnering with Eurobiomed on international missions (e.g., Business Tour Canada), business development programs (Expand USA), and export support for health innovation companies.
• HaxoneominorChannel Partner/ Reseller/ DistributorHaxoneo is a purchasing group (groupement d'achats) offering Eurobiomed members access to 'grand compte' pricing for professional purchases across 60 categories including IT, office supplies, and industrial equipment, through mutualization of 15,000 member volumes.
• Fisher Scientific (Thermo Fisher)minorChannel Partner/ Reseller/ DistributorFisher Scientific, part of Thermo Fisher Scientific, appears as a partner/logo on the Eurobiomed website, likely offering preferential purchasing terms or services to Eurobiomed members.
• TaleezminorChannel Partner/ Reseller/ DistributorTaleez, a recruitment platform, is listed as a partner on the Eurobiomed website, providing hiring services to Eurobiomed member companies.
• CCI Provence-Alpes-Côte d'AzurminorChannel Partner/ Reseller/ DistributorChambre de Commerce et d'Industrie Provence-Alpes-Côte d'Azur partners with Eurobiomed on international business development missions such as Business Tour Canada.
• Université Côte d'Azur / CRM INSERMmajorStrategic or Co-development PartnerEurobiomed co-pilots Skin Excellence with Prof. Thierry Passeron's team at INSERM/Université Côte d'Azur, dedicated to studying molecular mechanisms involved in pigmentation and melanoma, contributing to the Skin Institute initiative.
• InExtenso Innovation CroissancesignificantImplementation/ SI/ Consulting PartnerInExtenso Innovation Croissance partners with Eurobiomed on Move2Digital, a digital transformation diagnostic and roadmap service co-financed by Europe, Région Sud, and Aix-Marseille-Provence metropolis.
• Ad'OCC (Région Occitanie)minorChannel Partner/ Reseller/ DistributorAd'OCC, the investment agency of Région Occitanie, partners with Eurobiomed on programs such as Medtech USA for international market development.
• Campus CyberminorStrategic or Co-development PartnerCampus Cyber partners with Eurobiomed on cybersecurity-themed Biorezo events in Sophia Antipolis addressing cyber threats in the health sector.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Medicon Village: Swedish life sciences innovation hub in Lund/Skåne operating as a cluster with member companies, labs, and events. Comparable regional cluster model focused on health innovation in a defined territory, though not French/Mediterranean.
• BioRN Cluster Management GmbH: Heidelberg/Rhine-Neckar life sciences cluster in Germany — comparable regional life-sciences cluster with members, partners, and an innovation hub model. Anchors a specific geographic territory but uses a similar ecosystem-building and member-services playbook.

Direct peers

• Lyonbiopôle Auvergne-Rhône-Alpes: French pôle de compétitivité covering Auvergne-Rhône-Alpes with the same competitiveness-cluster mandate focused on human/animal health innovation. Identical legal model (association), identical funding mix (regional/national/EU), and overlapping program portfolio (accelerations, fundraising prep, international missions) make it the closest French peer.
• BioValley France: Grand Est health innovation cluster (pôle de compétitivité) serving the Alsace life sciences ecosystem. Same French cluster model, same advisory/acceleration service mix, and same regional/EU funding dependencies, making it a structural twin to Eurobiomed.
• Atlanpole Biothérapies: Western France (Pays de la Loire / Bretagne) health competitiveness cluster specializing in biotherapies and immuno-oncology. Operates the same membership/advisory model under French competitiveness cluster policy and competes for national visibility and member funding programs.
• One Nucleus: UK-based life sciences and healthcare membership organization serving the Cambridge/London corridor. Comparable as a not-for-profit cluster running investor introduction, networking, and international development services for life sciences members.
• Medicen Paris Region: Paris-Île-de-France health competitiveness cluster, also labelled pôle de compétitivité and focused on biotech, medtech, and digital health. Same French cluster policy framework, similar advisory + acceleration + international development services, and direct competitor for national funding visibility and member companies.
• Biocom California: California life sciences association representing 1,800+ member companies across biotech, medtech, and digital health. Functions as a much larger scale twin of Eurobiomed's regional cluster model, and is also Eurobiomed's strategic cross-border partner.
• Cancer Bio Santé: Occitanie-based French competitiveness cluster dedicated to oncology innovation. Operates with the same cluster mandate, public funding mix, and program types as Eurobiomed, and partially overlaps geographically within the same Occitanie region.

Broad incumbents

• BioIndustry Association (BIA): UK trade association for the life sciences and biotech industry with national remit. Overlaps with Eurobiomed on policy advocacy, funding access, and ecosystem connectivity, but at a much broader national scale rather than a regional territorial cluster.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/eurobiomed
• Xx.com/PoleEurobiomed

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurobiomed